Charles River Laboratorie(CRL.US)

Last Updated 19:00:00 ET
longbridge loading

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

MarketWatch Automated·
US
CRL
-0.72%
US
BBH
+0.33%
US
ARKG
+1.71%
MarketWatch Automated·
US
CRL
-0.72%
US
BBH
+0.33%
US
ARKG
+1.71%

A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Weakness

Simplywall·
US
CRL
-0.72%
US
IHF
+0.59%
US
ARKG
+1.71%
Simplywall·
US
CRL
-0.72%
US
IHF
+0.59%
US
ARKG
+1.71%

Charles River Laboratories International Inc. Stock Underperforms Thursday When Compared To Competitors

MarketWatch Automated·
US
CRL
-0.72%
US
LABU
+8.65%
US
IBBQ
+1.62%
MarketWatch Automated·
US
CRL
-0.72%
US
LABU
+8.65%
US
IBBQ
+1.62%

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

MarketWatch Automated·
US
CRL
-0.72%
MarketWatch Automated·
US
CRL
-0.72%

Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing

Fidelity·
US
CRL
-0.72%
US
XLV
+0.28%
US
LABD
-8.62%
Fidelity·
US
CRL
-0.72%
US
XLV
+0.28%
US
LABD
-8.62%

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared To Competitors

MarketWatch Automated·
US
CRL
-0.72%
US
IBB
+1.75%
US
FBT
+0.76%
MarketWatch Automated·
US
CRL
-0.72%
US
IBB
+1.75%
US
FBT
+0.76%

Charles River Labs: Buy Rating Reiterated as 2026 Outlook Strengthens; $235 Price Target Maintained

Tip Ranks·
US
CRL
-0.72%
US
IBB
+1.75%
US
IDNA
+2.34%
Tip Ranks·
US
CRL
-0.72%
US
IBB
+1.75%
US
IDNA
+2.34%

Charles River Laboratories International (NYSE:CRL) Issues Earnings Results

Market Beat·
US
CRL
-0.72%
US
FBT
+0.76%
US
BBH
+0.33%
Market Beat·
US
CRL
-0.72%
US
FBT
+0.76%
US
BBH
+0.33%
© 2026 Longbridge｜Disclaimer